Lantheus outlines $1.4B-$1.45B 2026 revenue forecast as company shifts focus to PET radiodiagnostics
Source: SeekingAlpha
2026-02-26 19:48:31 ET
More on Lantheus Holdings
- Lantheus Holdings, Inc. (LNTH) Q4 2025 Earnings Call Transcript
- Lantheus Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Lantheus: Management And Competition Raise Real Concern (Rating Downgrade)
- Lantheus Holdings reports mixed Q4 results; introduces FY26 outlook
- Lantheus Holdings Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Lantheus outlines $1.4B–$1.45B 2026 revenue forecast as company shifts focus to PET radiodiagnostics
Lantheus Holdings Inc.
NASDAQ: LNTH
LNTH Trading
5.59% G/L:
$82 Last:
449,559 Volume:
$79.37 Open:
LNTH Latest News
March 06, 2026 04:01:00 pm
Lantheus Announces FDA Approval of PYLARIFY TruVu(TM) (piflufolastat F 18) Injection
LNTH Stock Data
$4,401,112,772
64,985,543
0.1%
159
N/A
Pharmaceuticals
Healthcare
US
Bedford
